Annual General Meeting of Shareholders to be held on June 30, 2022René Beukema joins management team as Chief Corporate Development Officer and General Counsel and is nominated to Management BoardGerard Platenburg to assume Chief Scientific Officer role, with le
… ProQR Announces AnnualMeeting of Shareholders LEIDEN, Netherlands & CAMBRIDGE, … retinal diseases (IRDs), today announced the AnnualGeneralMeeting of Shareholders will take place on Wednesday, …
… ProQR Announces AnnualMeeting of Shareholders Leiden, Netherlands & Cambridge, … genetic rare diseases, today announced that the AnnualGeneralMeeting of Shareholders will take place on Tuesday, …
Development of Axiomer® RNA base editing technology platform continues across multiple therapeutic areas; initial pipeline targets to be disclosed in early 2023 with Analyst and Investor R&D event to be held in Q1 2023
Management Team appointments and p
Preclinical proof of concept data for the AX-0810 program targeting NTCP for cholestatic diseases presented at ASGCT 27th Annual Meeting – Management to host webinar today at 8:00 am EDT to highlight dataMartin Maier, PhD nominated to Board with Annual General
… ProQR Announces AnnualMeeting of Shareholders LEIDEN, the Netherlands, April 10, … N.V. (Nasdaq:PRQR) today announced that the AnnualGeneralMeeting of Shareholders will be held on Wednesday, …